Define a good prognosis of RNF43 codon 659-mutated and concomitant genomic signatures in CRC: an analysis of the cBioPortal database
In CRC, we found that the G1 cohort had the best prognosis, and patients with <i>RNF43</i> Non-codon 659-mutated, <i>BRAF</i> V600E and MSS had the worst prognosis. This may provide clinical value for patients' further accurate prognosis prediction, curative effect prediction, and follow-up management of patients.
Authors
- Xueqing Hu (ORCID: https://orcid.org/0000-0002-6008-917X)
- Yingying Huang (ORCID: https://orcid.org/0000-0002-0073-8780)
- Lei Qin (ORCID: https://orcid.org/0000-0002-5528-5336)
- Shuai Zhang (ORCID: https://orcid.org/0000-0003-2721-8395)
- Feng Wang (ORCID: https://orcid.org/0000-0003-1089-3095)
- Yunbo Zhao
- Liang‐In Lin (ORCID: https://orcid.org/0000-0002-3561-1093)
- Zhongkang Li (ORCID: https://orcid.org/0000-0003-1562-2438)
Institutions
- Peking University (CN)
- Beijing Hospital (CN)
- Annoroad Gene Technology (China) (CN)
- Peking University International Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3389/fonc.2025.1608664
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00